Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Twentyman

Showing results (141-150 of 153) with videos related to

Pageof 16
Sort By:
Biochemical Pharmacology|November 9, 1995
Localisation of the multidrug resistance-associated protein, MRP, in resistant large-cell lung tumour cellsM A Barrand, K J Robertson, S Y Neo, et al.
International Journal of Cancer|March 15, 1988
Establishment and characterization of cisplatin-resistant sublines of human lung cancer cell linesW S Hong, N Saijo, Y Sasaki, et al.
British Journal of Cancer|May 1, 1986
The in vitro effects and cross-resistance patterns of some novel anthracyclinesP R Twentyman, N E Fox, K A Wright, et al.
Japanese Journal of Cancer Research : Gann|November 1, 1987
In vitro growth inhibition of cisplatin-resistant human lung cancer cell lines by recombinant human tumor necrosis factor and/or recombinant human interferon-gamma by virtue of collateral sensitivityW S Hong, N Saijo, Y Sasaki, et al.
Journal of Molecular Endocrinology|July 1, 1989
Pro-opiomelanocortin gene expression and peptide secretion in human small-cell lung cancer cell linesA White, M F Stewart, W E Farrell, et al.
Genomics|January 1, 1991
An unusually proximal deletion on the short arm of chromosome 3 in a patient with small cell lung cancerM C Daly, J B Douglas, N M Bleehen, et al.
MMWR. Morbidity and Mortality Weekly Report|July 24, 2020
Estimated County-Level Prevalence of Selected Underlying Medical Conditions Associated with Increased Risk for Severe COVID-19 Illness - United States, 2018Hilda Razzaghi, Yan Wang, Hua Lu, et al.
British Journal of Haematology|April 1, 1997
Intermittent exposure to doxorubicin in vitro selects for multifactorial non-P-glycoprotein-associated multidrug resistance in RPMI 8226 human myeloma cellsB Wyler, Y Shao, E Schneider, et al.
Journal of the National Cancer Institute|April 5, 1995
Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinomaC A Boocock, D S Charnock-Jones, A M Sharkey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Phase I study of etoposide with SDZ PSC 833 as a modulator of multidrug resistance in patients with cancerD J Boote, I F Dennis, P R Twentyman, et al.
Pageof 16

Showing results (141-150 of 153) with videos related to

Sort By:
Pageof 16
Biochemical Pharmacology|November 9, 1995
Localisation of the multidrug resistance-associated protein, MRP, in resistant large-cell lung tumour cellsM A Barrand, K J Robertson, S Y Neo, et al.
International Journal of Cancer|March 15, 1988
Establishment and characterization of cisplatin-resistant sublines of human lung cancer cell linesW S Hong, N Saijo, Y Sasaki, et al.
British Journal of Cancer|May 1, 1986
The in vitro effects and cross-resistance patterns of some novel anthracyclinesP R Twentyman, N E Fox, K A Wright, et al.
Japanese Journal of Cancer Research : Gann|November 1, 1987
In vitro growth inhibition of cisplatin-resistant human lung cancer cell lines by recombinant human tumor necrosis factor and/or recombinant human interferon-gamma by virtue of collateral sensitivityW S Hong, N Saijo, Y Sasaki, et al.
Journal of Molecular Endocrinology|July 1, 1989
Pro-opiomelanocortin gene expression and peptide secretion in human small-cell lung cancer cell linesA White, M F Stewart, W E Farrell, et al.
Genomics|January 1, 1991
An unusually proximal deletion on the short arm of chromosome 3 in a patient with small cell lung cancerM C Daly, J B Douglas, N M Bleehen, et al.
MMWR. Morbidity and Mortality Weekly Report|July 24, 2020
Estimated County-Level Prevalence of Selected Underlying Medical Conditions Associated with Increased Risk for Severe COVID-19 Illness - United States, 2018Hilda Razzaghi, Yan Wang, Hua Lu, et al.
British Journal of Haematology|April 1, 1997
Intermittent exposure to doxorubicin in vitro selects for multifactorial non-P-glycoprotein-associated multidrug resistance in RPMI 8226 human myeloma cellsB Wyler, Y Shao, E Schneider, et al.
Journal of the National Cancer Institute|April 5, 1995
Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinomaC A Boocock, D S Charnock-Jones, A M Sharkey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Phase I study of etoposide with SDZ PSC 833 as a modulator of multidrug resistance in patients with cancerD J Boote, I F Dennis, P R Twentyman, et al.
Pageof 16